Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases by Marion Mussbacher, Laura Brunnthaler, Anja Panhuber, Patrick Starlinger, Alice Assinger

“…Platelets, in return, participate in a variety of liver diseases, ranging from non-alcoholic fatty liver diseases, (viral) hepatitis, liver fibrosis and hepatocellular carcinoma to liver regeneration. …”
Get full text

The effect of liver disease on hepatic microenvironment and implications for immune therapy by Zachary J. Brown, Samantha M. Ruff, Timothy M. Pawlik

“…Liver disease such as viral hepatitis, alcohol induced liver disease, and non-alcoholic fatty liver disease is a major risk factor for the development of HCC and has been demonstrated to alter the immune microenvironment. …”
Get full text

All-Atom MD Simulations of the HBV Capsid Complexed with AT130 Reveal Secondary and Tertiary Structural Changes and Mechanisms of Allostery by Carolina Pérez-Segura, Boon Chong Goh, Jodi A. Hadden-Perilla

“…The hepatitis B virus (HBV) capsid is an attractive drug target, relevant to combating viral hepatitis as a major public health concern. Among small molecules known to interfere with capsid assembly, the phenylpropenamides, including AT130, represent an important antiviral paradigm based on disrupting the timing of genome packaging. …”
Get full text

Predict of the development of lipid distress syndrome in patients with a sustained response to antiviral therapy of chronic hepatitis C by D. Yu. Konstantinov, G. V. Nedugov

“…The aim. is to develop a method, for predicting the development of lipid, distress syndrome in patients with a sustained, response to antiviral therapy of chronic viral hepatitis C on the basis of clinical and laboratory data.Materials and. methods. …”
Get full text

Treatment of TB/HIV co-infected patients in a day center by A. K. Ivanov, E. V. Shevyreva, N. A. Skrynnik, N. A. Tursunova, V. V. Manina, V. V. Nechaev

“…In patients with TB/HIV co-infection, viral hepatitis was diagnosed statistically significantly more often than among HIV negative tuberculosis patients (82.3% versus 11.3%; p < 0.01). …”
Get full text

A patient with dyskeratosis congenita and portal hypertension by Min Wei, Yuanyuan Liu, Jinhou Li, Hongxia Wang, Yanjing Gao

“…This condition is frequently associated with viral hepatitis and chronic alcohol abuse, and its complications, such as ascites, hepatic encephalopathy, and esophageal varices, have a considerable impact on mortality. …”
Get full text

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression by Ming-Ling Chang, Zinger Yang, Sien-Sing Yang

“…Obesity-related digestive diseases, including gastroesophageal reflux disease, Barrett’s esophagus, esophageal cancer, colon polyps and cancer, non-alcoholic fatty liver disease, viral hepatitis-related diseases, cholelithiasis, gallbladder cancer, cholangiocarcinoma, pancreatic cancer, and diabetes, might cause specific alterations in adipokine profiles. …”
Get full text

TRIF-dependent signaling and its role in liver diseases by Lilin Hu, Zilu Cheng, Huikuan Chu, Weijun Wang, Yu Jin, Ling Yang

“…Furthermore, we provide an overview of TRIF’s impact on several liver disorders, including drug-induced liver injury, ischemia-reperfusion liver injury, autoimmune hepatitis, viral hepatitis, alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). …”
Get full text

Safety of community drinking-water and outbreaks of waterborne enteric disease: Israel, 1976-97 by Tulchinsky Theodore H., Burla Etti, Clayman Marla, Sadik Chantal, Brown Alex, Goldberger Shalom

“…Long-term trends in the total incidence of reported infectious enteric diseases from all sources, including typhoid, shigellosis, and viral hepatitis (all types) declined, while the total incidence of salmonellosis increased. …”
Get full text

Features of the course of syphilis in HIV infected patients by S. V. Koshkin, A. L. Evseeva, V. V. Ryabova, O. S. Kovrova

“…Research data on the incidence of STIs (urogenital infections caused by Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis, Chlamydia trachomatis, syphilis) and viral hepatitis B and C in 60 HIV-positive prisoners in the Kirov region are presented. …”
Get full text

The Role of Cannabidiol in Liver Disease: A Systemic Review by Si Chen, Jeon-Kyung Kim

“…Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and viral hepatitis stand as prominent causes of morbidity and mortality in chronic liver diseases globally. …”
Get full text

Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection by Margaux J. Heuschkel, Thomas F. Baumert, Eloi R. Verrier

“…Chronic hepatitis D is one of the most severe and aggressive forms of chronic viral hepatitis with a high risk of developing hepatocellular carcinoma (HCC). …”
Get full text

Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa by Schoub B.D., Matai U., Singh B., Blackburn N.K., Levin J.B.

“…OBJETIVE: To evaluate the effectiveness of universal vaccination against viral hepatitis B in South Africa among 18-month-old rural children. …”
Get full text

Role of Portuguese community pharmacy and pharmacists in self-care by Filipa Alves da Costa, Ema Paulino, Sofia Crisóstomo

“…The fight to end AIDS and viral hepatitis is another example where community pharmacies promote self-testing and ensure efficient screening and referral to diagnosis and treatment. …”
Get full text

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis by O. D. Olisov, M. S. Novruzbekov, I. E. Galankina, L. N. Zimina, V. A. Gulyaev, L. V. Donova, M. Sh. Khubutiya

“…Hepatocellular carcinoma is one of the most common types of cancer, which occurs mainly in patients with liver cirrhosis and chronic viral hepatitis. Only about 10 % of HCC develops in non-cirrhotic liver among young and somatically healthy patients. 1-, 3-, 5-year recurrence-free and overall survival in LT group was significantly better than in the control group.Conclusion.  …”
Get full text

Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells by Wei Xiong, Yong Liao, Ji-Yong Qin, Wen-Hui Li, Zhao-You Tang

Get full text

Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 by E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin

“…IFNs are widely used in the treatment of multiple sclerosis, viral hepatitis B and C, and some forms of cancer. Preliminary clinical data support the efficacy of type I IFN against potential pandemic viruses such as Ebola and SARS. …”
Get full text

HDVdb: A Comprehensive Hepatitis D Virus Database by Zainab Usman, Stoyan Velkov, Ulrike Protzer, Michael Roggendorf, Dmitrij Frishman, Hadi Karimzadeh

“…Hepatitis D virus (HDV) causes the most severe form of viral hepatitis, which may rapidly progress to liver cirrhosis and hepatocellular carcinoma (HCC). …”
Get full text

Cryoglobulinemic vasculitis: literature review and clinical case by Palhuyeva H.Y., Makarenko E.V., Lahutchau V.V.

“…CV is often associated with lymphoproliferative diseases such as diffuse large B-cell lymphoma or non-Hodgkin’s lymphoma, autoimmune and infectious diseases. Viral hepatitis C is the most common underlying cause of CV and makes up approximately 80% of all cases. …”
Get full text

Optimal control strategies for preventing hepatitis B infection and reducing chronic liver cirrhosis incidence by Mst. Shanta Khatun, Md. Haider Ali Biswas

“…Among liver diseases, viral hepatitis is the major risk factor for chronic cirrhosis development. …”
Get full text